ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000261079.1	Ponatinib	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.001277781	Sensitive
ENSG00000261079.1	Ponatinib	Head and neck squamous cell carcinoma	0.001736503	Resistant